subscribeSubscribe
price-trendAsk Us
Results from First Clinical Study Using Danoprevir to Treat Naive & COVID-19

Results from First Clinical Study Using Danoprevir to Treat Naive & COVID-19
BIOSPACE
25 Mar 2020
Share Share
Clinical Trial of Ganovo® & Ritonavir Combination Therapy Coronavirus Pneumonia

Clinical Trial of Ganovo® & Ritonavir Combination Therapy Coronavirus Pneumonia
PR NEWSWIRE
26 Feb 2020
Share Share
Ascletis opens Clinical Development Shanghai Center

Ascletis opens Clinical Development Shanghai Center
BIOSPECTRUMASIA
12 Aug 2019
Share Share
Roche ties up again with Ascletis, partnership for hep B drug

Roche ties up again with Ascletis, partnership for hep B drug
Amber Tong ENDPTS
20 Nov 2018
Share Share
Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO

Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO
Amber Tong ENDPTS
18 Jul 2018
Share Share
Ascletis Receives NDA Approval from China FDA for Ganovo

Ascletis Receives NDA Approval from China FDA for Ganovo
PR NEWSWIRE
12 Jun 2018
Share Share
Epclusa`s fast-tracked Chinese approval might be late for Gilead

Epclusa`s fast-tracked Chinese approval might be late for Gilead
Angus Liu FIERCE PHARMA
31 May 2018
Share Share
Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference

Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference
Array BioPharma Inc. PR NEWSWIRE
05 Mar 2018
Share Share
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report

Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Angus Liu FIERCE PHARMA
06 Jan 2018
Share Share